advice
Workplace advice for any issue, problem, or concern; from changing careers to co-working advice and decorating needs.
United States Hemostats Market Demonstrates Steady Growth Fueled by Rising Surgical Volumes and Technological Advancements in Hemostatic Agents. AI-Generated.
The Global hemostats market, valued at US$1.23 billion in 2024, is projected to reach approximately US$1.35 billion in 2025 and expand at a CAGR of 6.8% from 2025 to 2030, driven by continuous advancements in surgical technology, rising adoption of minimally invasive procedures, and the growing need for efficient blood loss management solutions. The market’s growth reflects the critical role of hemostatic agents in improving surgical outcomes, minimizing postoperative complications, and enhancing patient recovery rates across diverse clinical specialties.
By Miss Prachee Bhartiyaabout a year ago in Journal
United States Precision Diagnostics & Medicine Industry Accelerates Toward a Data-Driven Future Fueled by AI, Genomics, and Personalized Therapies. AI-Generated.
The United States Precision Diagnostics & Medicine Industry is entering a new era of transformation, driven by the convergence of artificial intelligence (AI), genomics, and next-generation diagnostic technologies. The global precision diagnostics and medicine market, valued at USD 145.53 billion in 2024, is projected to reach USD 246.66 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period.
By Miss Prachee Bhartiyaabout a year ago in Journal
United States Organ Preservation Market to Experience Strong Growth Fueled by Rising Transplant Procedures and Advances in Preservation Technologies. AI-Generated.
The Global Organ Preservation Market is projected to witness strong growth in the coming years, supported by the increasing number of organ transplantation procedures, technological advancements in preservation methods, and rising public awareness around organ donation. The global organ preservation market, valued at USD 0.24 billion in 2024, is expected to reach USD 0.36 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
By Miss Prachee Bhartiyaabout a year ago in Journal
United States Peptide Synthesis Market Poised for Robust Growth Driven by Rising Therapeutic Applications and Technological Advancements. AI-Generated.
The United States Peptide Synthesis Market is witnessing a strong upward trajectory, driven by the surging demand for peptide-based therapeutics, innovations in synthesis technology, and growing applications in drug discovery and diagnostics. Peptides have become integral components in modern medicine—used as hormones, enzymes, antigens, and drug candidates—fueling a wave of research and development across the pharmaceutical and biotechnology industries.
By Miss Prachee Bhartiyaabout a year ago in Journal
United States Immunoassay Market Set for Steady Expansion Driven by Rising Chronic Disease Burden and Technological Advancements in Diagnostics. AI-Generated.
The United States immunoassay market, valued at US$35.5 billion in 2025, is projected to reach US$47.7 billion by 2030, advancing at a CAGR of 6.1% during the forecast period. Growth is driven by increasing diagnostic demand for infectious and chronic diseases, rising investments in R&D, and continuous technological advancements in immunodiagnostic platforms. With healthcare systems emphasizing early detection, personalized medicine, and preventive care, immunoassay technologies have become indispensable tools across hospitals, clinical laboratories, and biotechnology companies.
By Miss Prachee Bhartiyaabout a year ago in Journal
Top Biosimilars Companies in 2025. AI-Generated.
The global biosimilars market is expected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a compound annual growth rate (CAGR) of 7.5% during the forecast period. This growth is driven by rising adoption rates, supportive regulatory frameworks, and a growing acceptance among healthcare professionals to include biosimilars in treatment regimens.
By Jennifer Reynoldsabout a year ago in Journal
Top Digital Health Companies in 2025 . AI-Generated.
Prominent players in the market include Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), Fitbit (US), Dexcom, Inc. (US), Boston Scientific Corporation (US), Masimo (US), Teladoc Health, Inc. (US), American Well (US), Hims & Hers Health, Inc. (US), Headspace inc. (US), Noom, Inc. (US), Cerebral Inc. (US), Epic System Corporation (US), Omada Health Inc. (US), Oracle (US), Click Therapeutics, Inc. (US), Welldoc, Inc. (US), and EverlyWell (US).
By Jennifer Reynoldsabout a year ago in Journal
Synthetic Biology Market worth $31.52 billion by 2029. AI-Generated.
The report "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029", is estimated to expand to a value of USD 31.52 billion by 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. Some of the prominent factors driving the growth of the market are the rising demand for bio-based products and rising funding in R&D and collaborations. Furthermore, Advancements in synthetic biology and the diverse applications of synthetic biology are expected to provide lucrative market growth. The demand for synthetic DNA and oligonucleotides is growing, driven by diversified applications in research, diagnostics, and therapeutic development. This factor is likely to contribute to the growth of synthetic biology, particularly in the healthcare and biotechnology field.
By Jennifer Reynoldsabout a year ago in Journal


